Senexon-S Alternatives Compared
| Senexon-S (docusate/senna) | MiraLAX (polyethylene glycol 3350) | Lactulose |
|
|---|
| Senexon-S (docusate/senna) | MiraLAX (polyethylene glycol 3350) | Lactulose |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Over-the-counter
Prescribed for Constipation - Acute. Senexon-S may also be used for purposes not listed in this medication guide. |
Prescription and OTC
Prescribed for Irritable Bowel Syndrome with Constipation, Constipation - Acute, Constipation, Bowel Preparation, Irritable Bowel Syndrome. MiraLAX may also be used for purposes not listed in this... View more |
Prescription only
Prescribed for Hepatic Encephalopathy, Constipation - Chronic, Constipation - Acute, Constipation. Lactulose may also be used for purposes not listed in this medication guide. |
Related suggestions Constipation, Acute
|
|||||||||||||||||||||||
| More about Senexon-S (docusate/senna) | More about MiraLAX (polyethylene glycol 3350) | More about Lactulose | ||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Be the first to share your experience with this drug. |
MiraLAX has an average rating of 7.2 out of 10 from a total of 260 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 23% reported a negative effect. |
Lactulose has an average rating of 7.5 out of 10 from a total of 149 ratings on Drugs.com. 68% of reviewers reported a positive effect, while 21% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
| Generic Availability | ||||||||||||||||||||||||||
|
N/A |
N/A |
Lower cost generic |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Senexon-S prices |
View all MiraLAX prices |
View all Lactulose prices |
||||||||||||||||||||||||
| Dosage Forms Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Other docusate/senna brands include: Colace 2-in-1, Doc-Q-Lax, Doculax, Docuzen, Dok Plus, Ex-Lax Gentle Strength, Gentlax S, Medi-Laxx, Peri-Colace, Senna Plus, Senna S, Senna-Time S, Sennalax-S, Senokot S, SenoSol-SS View more | Other polyethylene glycol 3350 brands include: ClearLax, GaviLAX, Gialax, GlycoLax, HealthyLax, PEG3350, Purelax, SunMark ClearLax | Cholac, Constilac, Enulose, Generlac, Kristalose | ||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category N
Not classified
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 219 drugs are known to interact with Senexon-S:
|
A total of 221 drugs are known to interact with MiraLAX:
|
A total of 248 drugs are known to interact with Lactulose:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
February 18, 1999 |
N/A |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
|
N/A |
||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.